LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway

References

• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164.
   PubMed Web of Science ®Google Scholar
• Mojtahedi Z, Mohmedi M, Rahimifar S, et al. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene. 2012;508(2):229–232.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu Y, Gong ZY, et al. Distinguishing rectal cancer from colon cancer based on the support vector machine method and RNA-sequencing data. Curr Med Sci. 2021;41(2):368–374.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359–369.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Malla RR. Microbiome conundrum in colon cancer: development, progression, and therapeutics. Crit Rev Oncog. 2020;25(2):129–139.
   PubMedGoogle Scholar
• Rosen AW, Degett TH, Gögenur I. Individualized treatment of colon cancer. Ugeskr Laeger. 2016;17:8.
   Google Scholar
• Wang J, Li S, Liu Y, et al. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med. 2020;9(1):361–373.
   PubMed Web of Science ®Google Scholar
• Bellizzi A, Sebastian S, Ceglia P, et al. Co-expression of CD133 + /CD44 + in human colon cancer and liver metastasis. J Cell Physiol. 2013;228(2):408–415.
   PubMed Web of Science ®Google Scholar
• Singh S, Chouhan S, Mohammad N, et al. Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3. FEBS Lett. 2017;591:1371–1382.
   PubMed Web of Science ®Google Scholar
• Suhail M, Tarique M, Muhammad N, et al. A critical transcription factor NF-kappaB as a cancer therapeutic target and its inhibitors as cancer treatment options. Curr Med Chem. 2021;28(21):4117–4132.
   PubMed Web of Science ®Google Scholar
• Rashmi R, Jayachandran K, Zhang J, et al. Glutaminase inhibitors induce thiol-mediated oxidative stress and radiosensitization in treatment-resistant cervical cancers. Mol Cancer Ther. 2020;19(12):2465–2475.
   PubMed Web of Science ®Google Scholar
• Singh SV, Chaube B, Mayengbam SS, et al. Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: role of monocarboxylate transporter. Biochim Biophys Acta Mol Basis Dis. 2021;1867(3):166011.
   PubMed Web of Science ®Google Scholar
• Zhuang W, Niu T, Li Z. MicroRNA miR-145-5p regulates cell proliferation and cell migration in colon cancer by inhibiting chemokine (C-X-C motif) ligand 1 and integrin α2. Bioengineered. 2021;12(2):9909–9917.
   PubMed Web of Science ®Google Scholar
• Gordeeva O. Cancer-testis antigens: unique cancer stem cell biomarkers and targets for cancer therapy. Semin Cancer Biol. 2018;53:75–89.
   PubMed Web of Science ®Google Scholar
• Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol. 2003;194(3):272–288.
   PubMed Web of Science ®Google Scholar
• Li Q, Ge Y, Chen X, et al. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer. J Cell Biochem. 2019;120(9):15190–15201.
   PubMed Web of Science ®Google Scholar
• Xu M, Lin B, Zheng D, et al. LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. Oncol Lett. 2021;21(6):442.
   PubMed Web of Science ®Google Scholar
• Sasahira T, Kurihara-Shimomura M, Nishiguchi Y, et al. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2020;21:3655.
   PubMed Web of Science ®Google Scholar
• Sasahira T, Kurihara M, Nakashima C, et al. LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration. Br J Cancer. 2016;115(1):52–58.
   PubMed Web of Science ®Google Scholar
• Martinez-Romero J, Bueno-Fortes S, Martín-Merino M, et al. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling. BMC Genomics. 2018;19(S8):857.
   PubMedGoogle Scholar
• Hanieh H, Ahmed EA, Vishnubalaji R, et al. SOX4: epigenetic regulation and role in tumorigenesis. Semin Cancer Biol. 2020;67:91–104.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xiao C, Feng Z, et al. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int. 2020;20(1):468.
   PubMed Web of Science ®Google Scholar
• Peng X, Liu G, Peng H, et al. SOX4 contributes to TGF-β-induced epithelial–mesenchymal transition and stem cell characteristics of gastric cancer cells. Genes Dis. 2018;5(1):49–61.
   PubMed Web of Science ®Google Scholar
• Chen D, Hu C, Wen G, et al. DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo. Calcif Tissue Int. 2018;102(1):117–127.
   PubMed Web of Science ®Google Scholar
• Lin CM, Fang CL, Hseu YC, et al. Clinical and prognostic implications of transcription factor SOX4 in patients with colon cancer. PLoS One. 2013;8(6):e67128.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Wang R, Ma Y, Zhan S, et al. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-kappaB pathway to induce VEGFA expression. Cell Death Dis. 2020;11(1):55.
   PubMed Web of Science ®Google Scholar
• Xiaoxia X, Jing S, Dongbin X, et al. Realgar nanoparticles inhibit migration, invasion and metastasis in a mouse model of breast cancer by suppressing matrix metalloproteinases and angiogenesis. Curr Drug Deliv. 2020;17(2):148–158.
   PubMed Web of Science ®Google Scholar
• Narayanankutty A. PI3K/ Akt/ mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence. Curr Drug Targets. 2019;20(12):1217–1226.
   PubMed Web of Science ®Google Scholar
• Yang Y-L, Chu J-Y, Wang M-R. Tumor genetic heterogeneity. <![CDATA[Hereditas (Beijing)]]>. 2013;35(1):1–9.
   PubMedGoogle Scholar
• Malla RR, Marni R. Angiogenesis: promising therapeutic target of metastatic colon cancer. Crit Rev Oncog. 2020;25(2):161–173.
   PubMedGoogle Scholar
• Hong L, Han Y, Zhou Y, et al. Angiogenesis-related microRNAs in colon cancer. Expert Opin Biol Ther. 2013;13(1):77–84.
   PubMed Web of Science ®Google Scholar
• de Castro Sant’ Anna C, Junior AGF, Soares P, et al. Molecular biology as a tool for the treatment of cancer. Clin Exp Med. 2018;18(4):457–464.
   PubMed Web of Science ®Google Scholar
• Herzig DO, Tsikitis VL. Molecular markers for colon diagnosis, prognosis and targeted therapy. J Surg Oncol. 2015;111(1):96–102.
   PubMed Web of Science ®Google Scholar
• Bai T, Lei PX, Zhou H, et al. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells. J Cell Mol Med. 2019;23(11):7349–7359.
   PubMed Web of Science ®Google Scholar
• Luo Z, Hao S, Yuan J, et al. Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p. Bioengineered. 2021;12(1):8100–8115.
   PubMed Web of Science ®Google Scholar
• Juríková M, Danihel Ľ, Polák Š, et al. Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 2016;118(5):544–552.
   PubMed Web of Science ®Google Scholar
• You A, Fu L, Li Y, et al. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3. Cell Cycle. 2020;19(10):1105–1121.
   PubMed Web of Science ®Google Scholar
• Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–467.
   PubMed Web of Science ®Google Scholar
• Zhu P, Hu C, Hui K, et al. The role and significance of VEGFR2(+) regulatory T cells in tumor immunity. Onco Targets Ther. 2017;10:4315–4319.
   PubMed Web of Science ®Google Scholar
• Tsai CN, Yu SC, Lee CW, et al. SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Oncogene. 2020;39(24):4695–4710.
   PubMed Web of Science ®Google Scholar
• Lee H, Goodarzi H, Tavazoie SF, et al. TMEM2 is a SOX4-regulated gene that mediates metastatic migration and invasion in breast cancer. Cancer Res. 2016;76(17):4994–5005.
   PubMed Web of Science ®Google Scholar
• Wu G, Zhu YZ, Zhang JC. Sox4 up-regulates Cyr61 expression in colon cancer cells. Cell Physiol Biochem. 2014;34(2):405–412.
   PubMedGoogle Scholar
• Chen J, Ju HL, Yuan XY, et al. SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis. Clin Transl Oncol. 2016;18(1):65–72.
   PubMed Web of Science ®Google Scholar
• Moreno CS. SOX4: the unappreciated oncogene. Semin Cancer Biol. 2020;67:57–64.
   PubMed Web of Science ®Google Scholar
• Liu J, Du W. LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein. Onco Targets Ther. 2019;12:4287–4295.
   PubMed Web of Science ®Google Scholar
• Lu C, Xie T, Guo X, et al. LncRNA DSCAM-AS1 promotes colon cancer cells proliferation and migration via regulating the miR-204/SOX4 axis. Cancer Manag Res. 2020;12:4347–4356.
   PubMed Web of Science ®Google Scholar
• Noorolyai S, Shajari N, Baghbani E, et al. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128.
   PubMed Web of Science ®Google Scholar
• Yu JS, Cui W. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development (Cambridge. England). 2016;143:3050–3060.
   Google Scholar
• Coutte L, Dreyer C, Sablin MP, et al. PI3K-AKT-mTOR pathway and cancer. Bull Cancer. 2012;99(2):173–180.
   PubMed Web of Science ®Google Scholar
• Ponnurangam S, Standing D, Rangarajan P, et al. Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth. Mol Cancer Ther. 2013;12(5):598–609.
   PubMed Web of Science ®Google Scholar
• Pal I, Mandal M. PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes. Acta Pharmacol Sin. 2012;33(12):1441–1458.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wang Y, Wang P, et al. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia. Cell Biol Int. 2020;44(8):1745–1759.
   PubMed Web of Science ®Google Scholar
• Mehta GA, Parker JS, Silva GO, et al. Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer. Breast Cancer Res Treat. 2017;162(3):439–450.
   PubMed Web of Science ®Google Scholar
• Xu X, Zong K, Wang X, et al. miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome. Cell Death Dis. 2021;12(4):350.
   PubMed Web of Science ®Google Scholar
• Bilir B, Osunkoya AO, WGt W, et al. SOX4 is essential for prostate tumorigenesis initiated by PTEN ablation. Cancer Res. 2016;76(5):1112–1121.
   PubMed Web of Science ®Google Scholar